Bausch Health Companies Stock

Bausch Health Companies ROCE 2024

Bausch Health Companies ROCE

-1.56

Ticker

BHC.TO

ISIN

CA0717341071

WKN

A2JQ1X

In 2024, Bausch Health Companies's return on capital employed (ROCE) was -1.56, a -22.11% increase from the -2.01 ROCE in the previous year.

Bausch Health Companies Aktienanalyse

What does Bausch Health Companies do?

Bausch Health Companies Inc is a Canadian pharmaceutical company that was founded in 2013. However, the company's history dates back to 1853 when John Jacob Bausch and Henry Lomb founded their own company in the USA. This company specialized in optical products, particularly eyeglass frames and lenses. Over the years, the company expanded its product range and also became involved in the production of contact lenses in the 1960s. In the 1970s, the company began to focus on the medical devices sector and expanded in this area through various acquisitions. In the 1990s, the company also established itself in the pharmaceutical sector by building various channels for the distribution of medications. In 2013, the company was renamed and restructured due to financial problems, and in the future, it operated under the name Bausch Health Companies Inc. The company's business model is based on the development, manufacture, and marketing of products in the medical and ophthalmology fields. The company works closely with various institutions such as doctors, pharmacies, and hospitals to ensure that its products are used optimally. The company operates in various areas, including: - Ophthalmology: Bausch Health Companies offers various products in the field of ophthalmology, including contact lenses, eye drops, and other medications that can be used to treat eye diseases such as cataracts or glaucoma. - Dermatology: The company also develops and markets products in the field of dermatology, including medications for the treatment of acne, rosacea, and psoriasis. - Gastroenterology: Bausch Health Companies also produces medications for the treatment of gastrointestinal diseases, such as medications for ulcers or inflammatory bowel diseases. - Neurology: The company manufactures medications for the treatment of neurological disorders, such as epilepsy or migraines. - Urology: Bausch Health Companies also offers products in the field of urology, including medications for the treatment of urinary tract infections or bladder problems. One of the most well-known products of Bausch Health Companies is the brand Bausch + Lomb, which operates in the field of ophthalmology and offers various contact lenses and eye drops. Another well-known product is Jublia, a medication for nail fungus. Overall, Bausch Health Companies is a leading company in the field of medicine and ophthalmology with a long history. With its diverse range of medications and products, it offers effective and reliable solutions for the treatment of various conditions to patients worldwide. Bausch Health Companies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Bausch Health Companies's Return on Capital Employed (ROCE)

Bausch Health Companies's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Bausch Health Companies's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Bausch Health Companies's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Bausch Health Companies’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Bausch Health Companies stock

What is the ROCE (Return on Capital Employed) of Bausch Health Companies this year?

The ROCE of Bausch Health Companies is -1.56 undefined this year.

How has the ROCE (Return on Capital Employed) of Bausch Health Companies developed compared to the previous year?

The ROCE of Bausch Health Companies has increased by -22.11% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Bausch Health Companies?

A high Return on Capital Employed (ROCE) indicates that Bausch Health Companies has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Bausch Health Companies?

A low ROCE (Return on Capital Employed) can indicate that Bausch Health Companies has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Bausch Health Companies impact the company?

An increase in the ROCE of Bausch Health Companies can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Bausch Health Companies affect the company?

A decrease in ROCE of Bausch Health Companies can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Bausch Health Companies?

Some factors that can affect Bausch Health Companies's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Bausch Health Companies so important for investors?

The ROCE of Bausch Health Companies is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Bausch Health Companies take to improve the ROCE?

To improve the ROCE, Bausch Health Companies can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Bausch Health Companies pay?

Over the past 12 months, Bausch Health Companies paid a dividend of 1.28 USD . This corresponds to a dividend yield of about 15.45 %. For the coming 12 months, Bausch Health Companies is expected to pay a dividend of 0 USD.

What is the dividend yield of Bausch Health Companies?

The current dividend yield of Bausch Health Companies is 15.45 %.

When does Bausch Health Companies pay dividends?

Bausch Health Companies pays a quarterly dividend. This is distributed in the months of April, June, September, December.

How secure is the dividend of Bausch Health Companies?

Bausch Health Companies paid dividends every year for the past 6 years.

What is the dividend of Bausch Health Companies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bausch Health Companies located?

Bausch Health Companies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bausch Health Companies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bausch Health Companies from 12/22/2010 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 11/10/2010.

When did Bausch Health Companies pay the last dividend?

The last dividend was paid out on 12/22/2010.

What was the dividend of Bausch Health Companies in the year 2023?

In the year 2023, Bausch Health Companies distributed 0 USD as dividends.

In which currency does Bausch Health Companies pay out the dividend?

The dividends of Bausch Health Companies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bausch Health Companies stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Bausch Health Companies

Our stock analysis for Bausch Health Companies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bausch Health Companies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.